Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.

BACKGROUND:Microbiome studies suggest the presence of an interaction between the human gut microbiome and soil-transmitted helminth. Upon deworming, a complex interaction between the anthelminthic drug, helminths and microbiome composition might occur. To dissect this, we analyse the changes that ta...

Full description

Bibliographic Details
Main Authors: Ivonne Martin, Yenny Djuardi, Erliyani Sartono, Bruce A Rosa, Taniawati Supali, Makedonka Mitreva, Jeanine J Houwing-Duistermaat, Maria Yazdanbakhsh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC6084808?pdf=render
_version_ 1818521199426142208
author Ivonne Martin
Yenny Djuardi
Erliyani Sartono
Bruce A Rosa
Taniawati Supali
Makedonka Mitreva
Jeanine J Houwing-Duistermaat
Maria Yazdanbakhsh
author_facet Ivonne Martin
Yenny Djuardi
Erliyani Sartono
Bruce A Rosa
Taniawati Supali
Makedonka Mitreva
Jeanine J Houwing-Duistermaat
Maria Yazdanbakhsh
author_sort Ivonne Martin
collection DOAJ
description BACKGROUND:Microbiome studies suggest the presence of an interaction between the human gut microbiome and soil-transmitted helminth. Upon deworming, a complex interaction between the anthelminthic drug, helminths and microbiome composition might occur. To dissect this, we analyse the changes that take place in the gut bacteria profiles in samples from a double blind placebo controlled trial conducted in an area endemic for soil transmitted helminths in Indonesia. METHODS:Either placebo or albendazole were given every three months for a period of one and a half years. Helminth infection was assessed before and at 3 months after the last treatment round. In 150 subjects, the bacteria were profiled using the 454 pyrosequencing. Statistical analysis was performed cross-sectionally at pre-treatment to assess the effect of infection, and at post-treatment to determine the effect of infection and treatment on microbiome composition using the Dirichlet-multinomial regression model. RESULTS:At a phylum level, at pre-treatment, no difference was seen in microbiome composition in terms of relative abundance between helminth-infected and uninfected subjects and at post-treatment, no differences were found in microbiome composition between albendazole and placebo group. However, in subjects who remained infected, there was a significant difference in the microbiome composition of those who had received albendazole and placebo. This difference was largely attributed to alteration of Bacteroidetes. Albendazole was more effective against Ascaris lumbricoides and hookworms but not against Trichuris trichiura, thus in those who remained infected after receiving albendazole, the helminth composition was dominated by T. trichiura. DISCUSSION:We found that overall, albendazole does not affect the microbiome composition. However, there is an interaction between treatment and helminths as in subjects who received albendazole and remained infected there was a significant alteration in Bacteroidetes. This helminth-albendazole interaction needs to be studied further to fully grasp the complexity of the effect of deworming on the microbiome. TRIAL REGISTRATION:ISRCTN Registy, ISRCTN83830814.
first_indexed 2024-12-11T01:47:53Z
format Article
id doaj.art-572e9e93ab644e41b5fb7726ce06c8d6
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-11T01:47:53Z
publishDate 2018-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-572e9e93ab644e41b5fb7726ce06c8d62022-12-22T01:24:50ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352018-08-01128e000662010.1371/journal.pntd.0006620Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.Ivonne MartinYenny DjuardiErliyani SartonoBruce A RosaTaniawati SupaliMakedonka MitrevaJeanine J Houwing-DuistermaatMaria YazdanbakhshBACKGROUND:Microbiome studies suggest the presence of an interaction between the human gut microbiome and soil-transmitted helminth. Upon deworming, a complex interaction between the anthelminthic drug, helminths and microbiome composition might occur. To dissect this, we analyse the changes that take place in the gut bacteria profiles in samples from a double blind placebo controlled trial conducted in an area endemic for soil transmitted helminths in Indonesia. METHODS:Either placebo or albendazole were given every three months for a period of one and a half years. Helminth infection was assessed before and at 3 months after the last treatment round. In 150 subjects, the bacteria were profiled using the 454 pyrosequencing. Statistical analysis was performed cross-sectionally at pre-treatment to assess the effect of infection, and at post-treatment to determine the effect of infection and treatment on microbiome composition using the Dirichlet-multinomial regression model. RESULTS:At a phylum level, at pre-treatment, no difference was seen in microbiome composition in terms of relative abundance between helminth-infected and uninfected subjects and at post-treatment, no differences were found in microbiome composition between albendazole and placebo group. However, in subjects who remained infected, there was a significant difference in the microbiome composition of those who had received albendazole and placebo. This difference was largely attributed to alteration of Bacteroidetes. Albendazole was more effective against Ascaris lumbricoides and hookworms but not against Trichuris trichiura, thus in those who remained infected after receiving albendazole, the helminth composition was dominated by T. trichiura. DISCUSSION:We found that overall, albendazole does not affect the microbiome composition. However, there is an interaction between treatment and helminths as in subjects who received albendazole and remained infected there was a significant alteration in Bacteroidetes. This helminth-albendazole interaction needs to be studied further to fully grasp the complexity of the effect of deworming on the microbiome. TRIAL REGISTRATION:ISRCTN Registy, ISRCTN83830814.http://europepmc.org/articles/PMC6084808?pdf=render
spellingShingle Ivonne Martin
Yenny Djuardi
Erliyani Sartono
Bruce A Rosa
Taniawati Supali
Makedonka Mitreva
Jeanine J Houwing-Duistermaat
Maria Yazdanbakhsh
Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.
PLoS Neglected Tropical Diseases
title Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.
title_full Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.
title_fullStr Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.
title_full_unstemmed Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.
title_short Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.
title_sort dynamic changes in human gut microbiome in relation to a placebo controlled anthelminthic trial in indonesia
url http://europepmc.org/articles/PMC6084808?pdf=render
work_keys_str_mv AT ivonnemartin dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT yennydjuardi dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT erliyanisartono dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT brucearosa dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT taniawatisupali dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT makedonkamitreva dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT jeaninejhouwingduistermaat dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia
AT mariayazdanbakhsh dynamicchangesinhumangutmicrobiomeinrelationtoaplacebocontrolledanthelminthictrialinindonesia